Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Gastrointestinal 2 Thoracic 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 349 Paclitaxel 310 Cyclophosphamide 286 Docetaxel 267 Carboplatin 215 Capecitabine 215 Letrozole 185 Fulvestrant 178 Doxorubicin 166 Bevacizumab 136 Anastrozole 120 Tamoxifen 117 pertuzumab 114 pembrolizumab 113 Epirubicin 110 exemestane 107 Vinorelbine 106 Gemcitabine 106 Albumin-Bound Paclitaxel 92 Lapatinib 84 130-nm albumin-bound paclitaxel 83 Radiotherapy 79 palbociclib 75 eribulin 73 Cisplatin 69 pyrotinib 66 Taxes 65 Everolimus 55 Goserelin 50 Drug Therapy 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ispinesib × Breast × Clear all

NCT00089973 2018-02-26

Study Of Ispinesib In Subjects With Breast Cancer

GlaxoSmithKline

Phase 2 Completed

50 enrolled 12 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡